OBJECTIVE: To evaluate whether sexual intercourse soon after adult male circumcision affected HIV risk. DESIGN: Combined analysis of data from African trials of men who were randomized to and underwent circumcision. METHODS: We examined two associations: early sex (intercourse <42 days after circumcision) and HIV acquisition at 3 months for the Orange Farm and Kisumu trials and at 6 months for the Rakai and Kisumu trials and incomplete wound healing at 1 month and seroconversion at 3 and 6 months for the Kisumu trial and at 6 months for the Rakai trial. RESULTS: Early sex was reported by 3.9% of participants in Kisumu, 5.4% in Rakai, and 22.5% in Orange Farm. HIV seroprevalence was 0.0% at 3 months and 1.9% at 6 months among 18-24-year-olds reporting early sex and 0.2% at 3 months and 0.6% at 6 months among those who did not report early sex. In pooled analyses, men reporting early sex did not have higher HIV infection risk at 3 or 6 months. In Kisumu, 16 (1.3%) men had incomplete wound healing at the 30-day visit. One (6.3%) of these seroconverted at 3 months compared with 2 (0.2%) of 1246 men with complete wound healing (P = 0.075). No association was observed between incomplete wound healing and seroconversion for Rakai participants. CONCLUSION: Most men delayed intercourse after circumcision. Early sex after circumcision was not associated with HIV risk, although the study power was limited. Nevertheless, men should delay intercourse to limit the potential for increased HIV risk until complete wound healing.
RCT Entities:
OBJECTIVE: To evaluate whether sexual intercourse soon after adult male circumcision affected HIV risk. DESIGN: Combined analysis of data from African trials of men who were randomized to and underwent circumcision. METHODS: We examined two associations: early sex (intercourse <42 days after circumcision) and HIV acquisition at 3 months for the Orange Farm and Kisumu trials and at 6 months for the Rakai and Kisumu trials and incomplete wound healing at 1 month and seroconversion at 3 and 6 months for the Kisumu trial and at 6 months for the Rakai trial. RESULTS: Early sex was reported by 3.9% of participants in Kisumu, 5.4% in Rakai, and 22.5% in Orange Farm. HIV seroprevalence was 0.0% at 3 months and 1.9% at 6 months among 18-24-year-olds reporting early sex and 0.2% at 3 months and 0.6% at 6 months among those who did not report early sex. In pooled analyses, men reporting early sex did not have higher HIV infection risk at 3 or 6 months. In Kisumu, 16 (1.3%) men had incomplete wound healing at the 30-day visit. One (6.3%) of these seroconverted at 3 months compared with 2 (0.2%) of 1246 men with complete wound healing (P = 0.075). No association was observed between incomplete wound healing and seroconversion for Rakai participants. CONCLUSION: Most men delayed intercourse after circumcision. Early sex after circumcision was not associated with HIV risk, although the study power was limited. Nevertheless, men should delay intercourse to limit the potential for increased HIV risk until complete wound healing.
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: John N Krieger; Robert C Bailey; John Opeya; Benard Ayieko; Felix Opiyo; Kawango Agot; Corette Parker; Jeckoniah O Ndinya-Achola; George A O Magoha; Stephen Moses Journal: BJU Int Date: 2005-11 Impact factor: 5.588
Authors: Godfrey Kigozi; Ronald H Gray; Maria J Wawer; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Renee Ridzon; Pius Opendi; Victor Sempijja; Absolom Settuba; Denis Buwembo; Valerian Kiggundu; Margaret Anyokorit; James Nkale; Nehemia Kighoma; Blake Charvat Journal: PLoS Med Date: 2008-06-03 Impact factor: 11.069
Authors: Nancy S Padian; Sandra I McCoy; Salim S Abdool Karim; Nina Hasen; Julia Kim; Michael Bartos; Elly Katabira; Stefano M Bertozzi; Bernhard Schwartländer; Myron S Cohen Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: Supriya D Mehta; Stephen Moses; Kawango Agot; Ian Maclean; Elijah Odoyo-June; Hong Li; Robert C Bailey Journal: J Infect Dis Date: 2013-07-30 Impact factor: 5.226
Authors: Joanne E Mantell; Jennifer A Smit; Jane L Saffitz; Cecilia Milford; Nzwakie Mosery; Zonke Mabude; Nonkululeko Tesfay; Sibusiso Sibiya; Letitia Rambally; Tsitsi B Masvawure; Elizabeth A Kelvin; Zena A Stein Journal: Sex Health Date: 2013-05 Impact factor: 2.706
Authors: Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731
Authors: Thomas A Odeny; Robert C Bailey; Elizabeth A Bukusi; Jane M Simoni; Kenneth A Tapia; Krista Yuhas; King K Holmes; R Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2014-02-01 Impact factor: 3.731